Natalie Stratton

548 total citations
6 papers, 65 citations indexed

About

Natalie Stratton is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Natalie Stratton has authored 6 papers receiving a total of 65 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Natalie Stratton's work include Cancer therapeutics and mechanisms (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Virus-based gene therapy research (1 paper). Natalie Stratton is often cited by papers focused on Cancer therapeutics and mechanisms (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Virus-based gene therapy research (1 paper). Natalie Stratton collaborates with scholars based in United Kingdom, United States and Sweden. Natalie Stratton's co-authors include David A. Largaespada, Susan K. Rathe, Branden A. Smeester, Branden S. Moriarity, Eric P. Rahrmann, Wendy A. Hudson, Kenta Yamamoto, Nicholas J. Slipek, Kyle Williams and Lauren J. Mills and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Bone.

In The Last Decade

Natalie Stratton

5 papers receiving 63 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Stratton United Kingdom 4 35 18 16 16 10 6 65
Hayley Donnella United States 5 65 1.9× 33 1.8× 26 1.6× 7 0.4× 4 0.4× 6 112
Kristy Berry United States 4 47 1.3× 21 1.2× 10 0.6× 10 0.6× 3 0.3× 18 71
James Berstler United States 4 48 1.4× 40 2.2× 15 0.9× 18 1.1× 13 1.3× 5 98
Anna Calinawan United States 3 54 1.5× 34 1.9× 10 0.6× 8 0.5× 8 0.8× 4 100
Gareth Hughes United Kingdom 3 41 1.2× 18 1.0× 8 0.5× 7 0.4× 5 0.5× 5 62
Verena Waller Switzerland 6 50 1.4× 27 1.5× 15 0.9× 6 0.4× 15 1.5× 7 90
Nadine Reischmann Germany 5 73 2.1× 31 1.7× 5 0.3× 8 0.5× 5 0.5× 5 97
Matthew R. Hart United States 5 24 0.7× 25 1.4× 9 0.6× 12 0.8× 2 0.2× 5 61
Tyler Hulett United States 6 40 1.1× 48 2.7× 8 0.5× 43 2.7× 27 2.7× 14 120
Janice Schindler‐Horvat United States 5 28 0.8× 30 1.7× 6 0.4× 16 1.0× 10 1.0× 6 71

Countries citing papers authored by Natalie Stratton

Since Specialization
Citations

This map shows the geographic impact of Natalie Stratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Stratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Stratton more than expected).

Fields of papers citing papers by Natalie Stratton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Stratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Stratton. The network helps show where Natalie Stratton may publish in the future.

Co-authorship network of co-authors of Natalie Stratton

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Stratton. A scholar is included among the top collaborators of Natalie Stratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Stratton. Natalie Stratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Stratton, Natalie & Jonathan R. Thompson. (2024). Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRAS-Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report. JTO Clinical and Research Reports. 5(4). 100661–100661. 1 indexed citations
3.
Smeester, Branden A., Nicholas J. Slipek, Natalie Stratton, et al.. (2020). Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma. Molecular Cancer Therapeutics. 19(12). 2528–2541. 13 indexed citations
4.
Smeester, Branden A., Nicholas J. Slipek, Emily J. Pomeroy, et al.. (2020). PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma. Bone. 136. 115353–115353. 28 indexed citations
5.
Barlaam, Bernard, Elaine Cadogan, Andrew D. Campbell, et al.. (2018). Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors. ACS Medicinal Chemistry Letters. 9(8). 809–814. 19 indexed citations
6.
Loddick, Sarah A., Luke Gaughan, Jim Growcott, et al.. (2012). Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer. Cancer Research. 72(8_Supplement). 3848–3848. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026